Physician profile
Joseph Schaffer
NPI 1275875775
$10,129.35
in general payments reported to CMS, 2019-2025
20 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,127 · 2020: $734 · 2021: $123 · 2022: $1,389 · 2023: $1,274 · 2024: $213 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027 · Travel and Lodging: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.49 |
| Travel and Lodging | $729.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,850.20 | 2019-2023 | |
| Alpha Orthopedic Systems | $3,797.94 | 2019-2023 | |
| Stryker Corporation | $1,302.87 | 2019 | |
| Smith+Nephew, INC. | $333.06 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Electronic Waveform Lab, INC. | $195.92 | 2024 | |
| Music City Medical Technologies, LLC | $163.20 | 2025 | |
| Wound Management Technologies, INC | $83.07 | 2019 | |
| Endo Pharmaceuticals INC. | $77.27 | 2020-2023 | Xiaflex |
| Ferring Pharmaceuticals INC. | $74.19 | 2019-2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $44.14 | 2021-2023 | Zilretta, Iovera, Exparel |
| Depuy Synthes Sales INC. | $43.65 | 2019-2021 | |
| Orthofix Medical, INC. | $23.32 | 2019-2021 | |
| Relievant Medsystems, INC. | $22.42 | 2022 | |
| Djo, LLC | $20.00 | 2021 | |
| Acumed LLC | $19.83 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.13 | 2020 | |
| Abbott Laboratories | $17.41 | 2022 | |
| Pacira Therapeutics, INC. | $14.49 | 2020 | |
| Linvatec Corporation | $14.16 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.